GB-24

N/A

Report date: 2025/02/18 11:52:56

Base Information

Drug NameGB-24
Drug Alias NameGB-24GB24
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionTumor necrosis factor superfamily member 15 modulatorsTumor necrosis factor superfamily member 14 modulators
TargetsTumor necrosis factor superfamily member 15Tumor necrosis factor superfamily member 14
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong Kexing Bio-Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Kexing Bio-Products Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A